Kovacs Shane William Charles — SEC Form 4 filings
SEC reporting owner CIK 1579397. 8 Form 4 filings on record with FilingPulse; latest filed 2026-01-15.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-16 to 2026-01-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 138,981 shares, $3,296,758 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 100,000 shares @ $28.73 ($2,873,000) in Olema Pharmaceuticals, Inc., filed 2026-01-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | CH. OPERATING & FINANCIAL OFF. | 8 | — | 5 legs · 138,981 sh · $3,296,758 | 9 |
Form 4 filings — Kovacs Shane William Charles
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-15 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 3,822 @ $28.01 · Sale (S): 100,000 @ $28.73 | EDGAR |
| 2025-12-09 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Gift (G): 75,000 @ $0 | EDGAR |
| 2025-12-01 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Gift (G): 225,000 @ $0 | EDGAR |
| 2025-03-03 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 320,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 68,250 @ $0 · Sale (S): 16,803 @ $9.37 · Sale (S): 17,950 @ $8.66 · Sale (S): 406 @ $9.39 | EDGAR |
| 2024-11-18 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Option exercise (M): 25,000 @ $7.02 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 304,500 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Option exercise (M): 50,000 @ $7.02 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579397 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →